Crunching the numbers for KODK... Refresh in a moment for the full analysis.
EASTMAN KODAK CO (KODK)
Healthcare
healthy
$12.28
Updated: 2026-04-12
73
TradeApes Score
add
Financial Strength
70
Healthy
Operating Trend
60
Healthy
Valuation
85
Strong
Capital Allocation
80
Strong
Risk
70
Healthy
Key Findings
+
Historically cheap — EV/EBITDA in bottom 25% of its 5-year range
−
Weak interest coverage — earnings barely cover debt service
See the full analysis
Quarterly financials, DCF valuation model, Watchlist, and Stock Screener.
Create Free Account
Scores and valuations are model outputs, not investment advice. TradeApes does not provide financial, tax, or investment advice.